IPOs on tap include: BG Medicine (BGMD), Ventrus Biosciences (VTUS). 8 others scheduled for the week of December 13 totaling $2 billion.
BG Medicine (BGMD): $67mm IPO with a market cap of $248 at the price range mid-point of $14. Scheduled for Wednesday, December 15, 2010.
BGMD is currently cash flow negative but deserves watching, to [...]
The headline article gives the impression that major drug companies missed the metabolomics boat when it sailed a few years ago. They didn't. They've been exploring the technology since its use in clinical studies first became practical. Note that metabolomics can theoretically be used in tandem with proteomics and genomics (and even glycomics) to predict [...]